{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:41:42Z","timestamp":1794357702707,"version":"4.9.0"},"reference-count":181,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.autrev.2025.103815","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T09:17:04Z","timestamp":1744622224000},"page":"103815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation"],"prefix":"10.1016","volume":"24","author":[{"given":"Valeria","family":"Carnazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Restante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krizia","family":"Pocino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103815_bb0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coi.2007.09.002","article-title":"The inflammasome: a danger sensing complex triggering innate immunity","volume":"19","author":"P\u00e9trilli","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103815_bb0025","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3389\/fimmu.2018.02379","article-title":"Pattern recognition receptors and the host cell death molecular machinery","volume":"9","author":"Amarante-Mendes","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMPs and DAMPs: signal 0s that spur autophagy and immunity","volume":"249","author":"Tang","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2025.103815_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1326.020","article-title":"Innate immune sensing of microbes by nod proteins","volume":"1072","author":"Kufer","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nri.2016.151","article-title":"Homeostasis-altering molecular processes as mechanisms of inflammasome activation","volume":"17","author":"Liston","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0045","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acscentsci.8b00218","article-title":"Immunomodulation of the NLRP3 inflammasome through structure-based activator design and functional regulation via lysosomal rupture","volume":"4","author":"Manna","year":"2018","journal-title":"ACS Cent Sci"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/eji.200940168","article-title":"Signaling by ROS drives inflammasome activation","volume":"40","author":"Martinon","year":"2010","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1194\/jlr.S091280","article-title":"Inflammasomes, neutrophil extracellular traps, and cholesterol","volume":"60","author":"Tall","year":"2019","journal-title":"Lipid Res"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.autrev.2011.10.008","article-title":"The fresco of autoinflammatory diseases from the pediatric perspective","volume":"11","author":"Rigante","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103815_bb0065","doi-asserted-by":"crossref","unstructured":"Qiu Z, He Y, Ming H, Lei S, Leng Y, Xia ZY.J. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia\/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. Diabetes Res 2019 2019:8151836. doi:https:\/\/doi.org\/10.1155\/2019\/8151836.","DOI":"10.1155\/2019\/8151836"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"issue":"23","key":"10.1016\/j.autrev.2025.103815_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316556","article-title":"NLRP3 inflammasome involvement in heart, liver, and lung diseases-a lesson from cytokine storm syndrome","volume":"24","author":"Napodano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103815_bb0080","article-title":"Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101100","article-title":"The human inflammasomes","volume":"88","author":"Paerewijck","year":"2022","journal-title":"Mol Asp Med"},{"issue":"13","key":"10.1016\/j.autrev.2025.103815_bb0090","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/cells12131766","article-title":"Inflammasomes: mechanisms of action and involvement in human diseases","volume":"12","author":"Bult\u00e9","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41590-021-00869-6","article-title":"Inflammasomes and adaptive immune responses","volume":"22","author":"Deets","year":"2021","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0100","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/ijms26051872","article-title":"The golden card of interleukin-1 blockers in systemic inflammasomopathies of childhood","volume":"26","author":"Rigante","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.51620\/0869-2084-2021-66-5-279-284","article-title":"Analysis of interferon type I signature for differential diagnosis of diseases of the immune system","volume":"66","author":"Suspitsin","year":"2021","journal-title":"Klin Lab Diagn"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/039463201102400315","article-title":"Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults","volume":"24","author":"Cantarini","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2025.103815_bb0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Annu. Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Rev Immunol"},{"issue":"7944","key":"10.1016\/j.autrev.2025.103815_bb0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","article-title":"Cryo-EM structures of the active NLRP3 inflammasome disc","volume":"613","author":"Xiao","year":"2023","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.autrev.2025.103815_bb0125","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2174\/0109298673289984231127062528","article-title":"Targeting NLRP3 inflammasome: structure, function, and inhibitors","volume":"31","author":"Lou","year":"2024","journal-title":"Curr Med Chem"},{"issue":"11","key":"10.1016\/j.autrev.2025.103815_bb0130","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.tcb.2021.06.010","article-title":"Cell biology of inflammasome activation","volume":"31","author":"Pandey","year":"2021","journal-title":"Trends Cell Biol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103815_bb0135","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41423-022-00922-w","article-title":"How location and cellular signaling combine to activate the NLRP3 inflammasome","volume":"19","author":"Akbal","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"26","key":"10.1016\/j.autrev.2025.103815_bb0140","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.cell.2021.11.011","article-title":"NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation","volume":"184","author":"Andreeva","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0145","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10753-021-01439-6","article-title":"The signaling pathways regulating NLRP3 inflammasome activation","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0150","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202006194","article-title":"The NLRP3-inflammasome as a sensor of organelle dysfunction","volume":"219","author":"Seoane","year":"2020","journal-title":"J Cell Biol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0155","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.it.2022.10.003","article-title":"The NLRP3 inflammasome: regulation by metabolic signals","volume":"43","author":"Olona","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0165","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0170","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.138.5.1447","article-title":"Studies on the molecular nature of human interleukin 1","volume":"138","author":"Auron","year":"1987","journal-title":"J Immunol"},{"issue":"17","key":"10.1016\/j.autrev.2025.103815_bb0175","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1073\/pnas.87.17.6487","article-title":"Interleukin-1 regulation of human endothelial cell proliferation in vitro","volume":"87","author":"Marceau","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"105","key":"10.1016\/j.autrev.2025.103815_bb0180","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2025.103815_bb0190","article-title":"NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0049-2016","article-title":"Inflammasomes in myeloid cells: warriors within","volume":"5","author":"Jha","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109720","article-title":"Proteopathic tau primes and activates interleukin-1beta via myeloid-cell-specific MyD88 and NLRP3-ASC-inflammasome pathway","volume":"36","author":"Jiang","year":"2021","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13567-019-0671-x","article-title":"Matrine inhibits IL-1beta secretion in primary porcine alveolar macrophages through the MyD88\/NF-kappaB pathway and NLRP3 inflammasome","volume":"50","author":"Sun","year":"2019","journal-title":"Vet Res"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0210","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/smll.201302825","article-title":"Polyhydroxylated metallofullerenols stimulate IL-1beta secretion of macrophage through TLRs\/MyD88\/NF-kappaB pathway and NLRP3 inflammasome activation","volume":"10","author":"Chen","year":"2014","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0215","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/icb.2016.87","article-title":"IL-1\u03b2\/CD14 pathway induces IL-17 production: dendritic cells activated with IL-1\u03b2 set Th17 cells on fire by CD14-mediated mechanisms","volume":"94","author":"Tosello Boari","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2025.103815_bb0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2017.07.022","article-title":"IL-33-matured dendritic cells promote Th17 cell responses via IL-1\u03b2 and IL-6","volume":"99","author":"Park","year":"2017","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0235","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2009.07.053","article-title":"IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome","volume":"208","author":"Tan","year":"2010","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0240","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.21037\/apm-21-2582","article-title":"Association between IL-18, IFN-gamma and TB susceptibility: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0245","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s40425-019-0652-7","article-title":"IL-27 enhances IL-15\/IL-18-mediated activation of human natural killer cells","volume":"7","author":"Choi","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0250","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/biof.107","article-title":"Cytokine regulation of natural killer cell effector functions","volume":"36","author":"Zwirner","year":"2010","journal-title":"Biofactor"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0255","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103815_bb0260","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lfs.2017.11.026","article-title":"Autoimmune thyroid diseases and Th17\/Treg lymphocytes","volume":"192","author":"Shao","year":"2018","journal-title":"Life Sci"},{"issue":"14","key":"10.1016\/j.autrev.2025.103815_bb0270","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.micinf.2012.07.007","article-title":"Control of innate and adaptive immunity by the inflammasome","volume":"14","author":"Ciraci","year":"2012","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0275","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.intimp.2010.11.025","article-title":"Regulation of adaptive immunity by the NLRP3 inflammasome","volume":"11","author":"Chen","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0280","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/09273948.2020.1811350","article-title":"Dysregulation of the NLRP3 inflammasome in diabetic retinopathy and potential therapeutic targets","volume":"30","author":"Raman","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"25","key":"10.1016\/j.autrev.2025.103815_bb0285","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2316551121","article-title":"Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7","volume":"121","author":"Yu","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0290","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/cells13080675","article-title":"Inhibition of immunoproteasome attenuates NLRP3 inflammasome response by regulating E3 ubiquitin ligase TRIM31","volume":"13","author":"Lee","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-022-00954-9","article-title":"The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation in helicobacter pylori-associated gastritis by regulating ROS and autophagy","volume":"21","author":"Yu","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0300","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/039463201102400402","article-title":"Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes","volume":"24","author":"Cantarini","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","article-title":"CAPS and NLRP3","volume":"39","author":"Booshehri","year":"2019","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","article-title":"New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation","volume":"19","author":"Kodi","year":"2024","journal-title":"J NeuroImmune Pharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0315","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2025.103815_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"issue":"14","key":"10.1016\/j.autrev.2025.103815_bb0325","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/cells11142231","article-title":"The clinical chameleon of autoinflammatory diseases in children","volume":"11","author":"Sangiorgi","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0330","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00296-023-05346-x","article-title":"Systemic lupus erythematosus: latest insight into etiopathogenesis","volume":"43","author":"Akhil","year":"2023","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0335","doi-asserted-by":"crossref","first-page":"17331","DOI":"10.3390\/ijms160817331","article-title":"Infections and systemic lupus erythematosus: binding or sparring partners?","volume":"16","author":"Rigante","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103815_bb0340","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3389\/fimmu.2018.01250","article-title":"Analysis of serum interleukin (IL)-1\u03b2 and IL-18 in systemic lupus erythematosus","volume":"9","author":"Mende","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103479","article-title":"Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - a proposal from an expert panel","volume":"22","author":"Rojo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103815_bb0350","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-016-0911-z","article-title":"Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages","volume":"14","author":"Zhang","year":"2016","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0355","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4049\/jimmunol.1201195","article-title":"Self double-stranded (ds) DNA induces IL-1\u03b2 production from human monocytes by activating NLRP3 inflammasome in the presence of anti\u2013dsDNA antibodies","volume":"190","author":"Shin","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0360","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2009.00863.x","article-title":"The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases","volume":"233","author":"Kattah","year":"2010","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0365","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0370","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI111569","article-title":"Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes","volume":"74","author":"LeFeber","year":"1984","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0375","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.1103355","article-title":"U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes","volume":"188","author":"Shin","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0380","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-induced pyroptotic cell death","volume":"243","author":"Miao","year":"2011","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0385","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0390","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00109-016-1421-4","article-title":"Cause and consequences of the activated type I interferon system in SLE","volume":"94","author":"Eloranta","year":"2016","journal-title":"J Mol Med"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0395","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2025.103815_bb0400","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.40166","article-title":"Enhanced inflammasome activity in systemic lupus erythematosus is mediated via type I interferon-induced up-regulation of interferon regulatory factor 1","volume":"69","author":"Liu","year":"2017","journal-title":"Arthritis Rheum"},{"issue":"22","key":"10.1016\/j.autrev.2025.103815_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212476","article-title":"The role of NLRP3 Inflammasome in lupus nephritis","volume":"22","author":"Oliveira","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0410","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MNH.0000000000000969","article-title":"New guidelines and therapeutic updates for the management of lupus nephritis","volume":"33","author":"Desai","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0415","first-page":"316","article-title":"Angiopoietin-like 4 (ANGPTL4) suppression ameliorates lupus nephritis in MRL\/lpr mice by inactivating NLRP3 inflammasome and inhibiting inflammatory response","volume":"20","author":"Luo","year":"2023","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0420","doi-asserted-by":"crossref","unstructured":"Smolen JS, Aletaha D, McInnes I.B. Rheumatoid arthritis. Lancet 2016;388(10055):2023\u201338. doi:https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8.","DOI":"10.1016\/S0140-6736(16)30173-8"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0425","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12016-014-8460-9","article-title":"The etiology of juvenile idiopathic arthritis","volume":"49","author":"Rigante","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0430","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.autrev.2015.02.004","article-title":"Hormonal modulation of the immune system - a spotlight on the role of progestogens","volume":"14","author":"Tan","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103815_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.816839","article-title":"Inflammasome and its therapeutic targeting in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931690","article-title":"Role of NLRP3 inflammasome in rheumatoid arthritis","volume":"13","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.010","article-title":"Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review","volume":"103","author":"Shin","year":"2019","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0450","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","article-title":"ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome","volume":"17","author":"Dong","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"10287","key":"10.1016\/j.autrev.2025.103815_bb0455","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.autrev.2025.103815_bb0460","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.3390\/ijms22168941","article-title":"Cell-free DNA in rheumatoid arthritis","volume":"22","author":"Hashimoto","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0465","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0470","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthrit Res Ther"},{"key":"10.1016\/j.autrev.2025.103815_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/782382","article-title":"The role of IL-1\u03b2 in the bone loss during rheumatic diseases","volume":"2015","author":"Ruscitti","year":"2015","journal-title":"Mediat Inflamm"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2025.103815_bb0480","first-page":"iii10","article-title":"The role of interleukin-1 in bone resorption in rheumatoid arthritis","volume":"43","author":"Strand","year":"2004","journal-title":"Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0485","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1902\/jop.2007.060392","article-title":"Gaffen SL Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy","volume":"78","author":"Kramer","year":"2007","journal-title":"J Periodontol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0490","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jbspin.2015.07.006","article-title":"Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner","volume":"83","author":"Yang","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0495","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/jir.2011.0050","article-title":"Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis","volume":"31","author":"Volin","year":"2011","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.autrev.2025.103815_bb0500","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10753-012-9524-8","article-title":"IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis","volume":"36","author":"Zhang","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2025.103815_bb0505","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2018.09.007","article-title":"NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis","volume":"197","author":"Zhao","year":"2018","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0510","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41419-021-03562-6","article-title":"Protectin DX restores Treg\/T(h)17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a","volume":"12","author":"Jin","year":"2021","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0515","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201700","article-title":"Inflammasome is a central player in B cell development and homing","volume":"6","author":"Hsu","year":"2022","journal-title":"Life Sci Alliance"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0520","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103815_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2018.02.010","article-title":"Systemic activation of NLRP3 inflammasome in patients with severe primary Sj\u00f6gren\u2019s syndrome fueled by inflammagenic DNA accumulations","volume":"91","author":"Vakrakou","year":"2018","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0530","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/diagnostics13020206","article-title":"NLRP3 gene polymorphisms in rheumatoid arthritis and primary Sjogren\u2019s syndrome patients","volume":"13","author":"Li","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.autrev.2025.103815_bb0535","article-title":"Ruscogenin ameliorated Sjogren\u2019s syndrome by inhibiting NLRP3 inflammasome activation","volume":"2022","author":"He","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0540","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrneph.2017.37","article-title":"Complement in ANCA-associated vasculitis: mechanisms and implications for management","volume":"13","author":"Chen","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0545","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of anti-neutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103815_bb0550","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/CVI.00137-08","article-title":"Antibodies to proteinase 3 prime human oral, lung, and kidney epithelial cells to secrete proinflammatory cytokines upon stimulation with agonists to various toll-like receptors, NOD1, and NOD2","volume":"15","author":"Uehara","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0555","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5414\/CN108902","article-title":"IL-1beta promotes tubulointerstitial injury in MPO-ANCA-associated glomerulonephritis","volume":"86","author":"Tashiro","year":"2016","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103815_bb0560","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/nep.12785","article-title":"The NLRP3 inflammasome in kidney disease and autoimmunity","volume":"21","author":"Hutton","year":"2016","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0565","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12967-019-1949-5","article-title":"The expression of NOD2, NLRP3 and NLRC5 and renal injury in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"17","author":"Wang","year":"2019","journal-title":"J Transl Med"},{"issue":"29","key":"10.1016\/j.autrev.2025.103815_bb0570","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2174\/0113816128312530240607051608","article-title":"Novel therapies for ANCA-associated vasculitis: apilimod ameliorated endothelial cells injury through TLR4\/NF-kappaB pathway and NLRP3 inflammasome","volume":"30","author":"Liu","year":"2024","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0575","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/cells12060918","article-title":"Molecular mechanisms in autoimmune thyroid disease","volume":"12","author":"Vargas-Uricoechea","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0580","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1210\/jc.2011-1568","article-title":"Innate immune activation and thyroid autoimmunity","volume":"96","author":"Kawashima","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2025.103815_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104659","article-title":"Pharmacological suppression of NLRP3 inflammasome attenuated the development of autoimmune thyroiditis","volume":"384","author":"Ding","year":"2023","journal-title":"Cell Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0590","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/jir.2011.0049","article-title":"Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity","volume":"31","author":"Ganesh","year":"2011","journal-title":"J Interf Cytokine Res"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0595","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0456","article-title":"Iodine activates NLRP3 inflammasomes in PBMCs of patients with autoimmune thyroiditis and regulates Th1 and Th17 cell differentiation","volume":"14","author":"Wu","year":"2025","journal-title":"Endocr Connect"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0600","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2613.2010.00715.x","article-title":"Thyrocyte interleukin-18 expression is up-regulated by interferon-gamma and may contribute to thyroid destruction in Hashimoto\u2019s thyroiditis","volume":"91","author":"Liu","year":"2010","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.autrev.2025.103815_bb0605","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3389\/fimmu.2018.01197","article-title":"Cytokine secretion and pyroptosis of thyroid follicular cells mediated by enhanced NLRP3, NLRP1, NLRC4, and AIM2 inflammasomes are associated with autoimmune thyroiditis","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"issue":"10138","key":"10.1016\/j.autrev.2025.103815_bb0610","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0615","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/cmi.2017.7","article-title":"miRNAs: novel regulators of autoimmunity-mediated pancreatic beta-cell destruction in type 1 diabetes","volume":"14","author":"Zheng","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0620","first-page":"7","article-title":"Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes","volume":"10","author":"Gao","year":"2017","journal-title":"BMC Med Genet"},{"issue":"36","key":"10.1016\/j.autrev.2025.103815_bb0625","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1073\/pnas.1513509112","article-title":"NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets","volume":"112","author":"Hu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0630","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/pr.2012.24","article-title":"Toll-like receptors, the NLRP3 inflammasome, and interleukin-1beta in the development and progression of type 1 diabetes","volume":"71","author":"Grishman","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2025.103815_bb0635","article-title":"Inflammasome and pyroptosis in autoimmune liver diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103815_bb0640","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3724\/abbs.2022137","article-title":"NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease","volume":"54","author":"Guan","year":"2022","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"9","key":"10.1016\/j.autrev.2025.103815_bb0645","article-title":"Recent advances in the diagnosis and management of autoimmune hepatitis","volume":"132","author":"Dalekos","year":"2022","journal-title":"Pol Arch Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0650","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the international autoimmune hepatitis group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0655","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.autrev.2025.103815_bb0660","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis-update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2025.103815_bb0665","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fimmu.2018.00758","article-title":"NOD-like receptor protein 3 inflammasome-dependent IL-1\u03b2 accelerated conA-induced hepatitis","volume":"9","author":"Luan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103815_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116033","article-title":"Deficiency of purinergic P2X4 receptor alleviates experimental autoimmune hepatitis in mice","volume":"221","author":"Liu","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0675","doi-asserted-by":"crossref","first-page":"170","DOI":"10.32074\/1591-951X-245","article-title":"Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0680","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103815_bb0685","doi-asserted-by":"crossref","DOI":"10.1590\/acb361106","article-title":"Paeoniflorin mitigates PBC-induced liver fibrosis by repressing NLRP3 formation","volume":"36","author":"Zhang","year":"2022","journal-title":"Acta Cir Bras"},{"issue":"10","key":"10.1016\/j.autrev.2025.103815_bb0690","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.3390\/cells10102618","article-title":"Bile acids activate NLRP3 inflammasome, promoting murine liver inflammation or fibrosis in a cell type-specific manner","volume":"10","author":"Holtmann","year":"2021","journal-title":"Cells"},{"issue":"10139","key":"10.1016\/j.autrev.2025.103815_bb0695","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0700","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/liv.15339","article-title":"Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0705","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","article-title":"Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis","volume":"68","author":"Liao","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0710","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajpath.2016.10.010","article-title":"NLRP3 activation in-duces IL-18 synthesis and affects the epithelial barrier function in reactive cholangiocytes","volume":"187","author":"Maroni","year":"2017","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0715","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5009\/gnl210116","article-title":"Classification and diagnostic criteria for IgG4-related sclerosing cholangitis","volume":"16","author":"Naitoh","year":"2022","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0720","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000020","article-title":"Activated T-follicular helper 2 cells are associated with disease activity in IgG4-related sclerosing cholangitis and pancreatitis","volume":"10","author":"Cargill","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0725","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jhep.2023.08.005","article-title":"IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies","volume":"79","author":"Kersten","year":"2023","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103815_bb0730","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: a promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0735","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0740","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1002\/jcb.27792","article-title":"Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis","volume":"120","author":"Xu","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.autrev.2025.103815_bb0745","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2021.03.055","article-title":"CY-09 attenuates the progression of osteoarthritis via inhibiting NLRP3 inflammasome-mediated pyroptosis","volume":"553","author":"Zhang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0750","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.autrev.2025.103815_bb0755","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015513","article-title":"Novel role for tranilast in regulating NLRP3 ubiquitination, vascular inflammation, and atherosclerosis","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0760","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","article-title":"NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis","volume":"20","author":"Marchetti","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.autrev.2025.103815_bb0765","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101082","article-title":"VX-765 inhibits pyroptosis and reduces inflammation to prevent acute liver failure by upregulating PPAR\u03b1 expression","volume":"28","author":"Jiao","year":"2023","journal-title":"Ann Hepatol"},{"issue":"14","key":"10.1016\/j.autrev.2025.103815_bb0775","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0780","first-page":"171","article-title":"Biologic agents and small-molecule inhibitors in systemic autoimmune conditions: an update","volume":"131","author":"Prieto-Pe\u00f1a","year":"2021","journal-title":"Pol Arch Intern Med"},{"issue":"23","key":"10.1016\/j.autrev.2025.103815_bb0785","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312958","article-title":"Association of inflammasome gene expression levels with pathogenesis of familial Mediterranean fever in Armenians","volume":"25","author":"Hayrapetyan","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0790","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12026-015-8686-5","article-title":"Elevated expression of NLRP3 in patients with immune thrombocytopenia","volume":"64","author":"Qiao","year":"2016","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0795","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103815_bb0800","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2017.09.019","article-title":"Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sj\u00f6gren\u2019s syndrome","volume":"474","author":"Kim","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"26","key":"10.1016\/j.autrev.2025.103815_bb0805","doi-asserted-by":"crossref","first-page":"E6065","DOI":"10.1073\/pnas.1722041115","article-title":"Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis","volume":"115","author":"McKenzie","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2025.103815_bb0810","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12950-018-0192-9","article-title":"Expression and clinical significance of the NEK7-NLRP3 inflammasome signaling pathway in patients with systemic lupus erythematosus","volume":"15","author":"Ma","year":"2018","journal-title":"J Inflamm (Lond)"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0815","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"10.1016\/j.autrev.2025.103815_bb0820","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s10620-017-4609-8","article-title":"Activation of NLRP3 Inflammasome in inflammatory bowel disease: differences between Crohn\u2019s disease and ulcerative colitis","volume":"62","author":"Lazaridis","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.autrev.2025.103815_bb0825","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102708","article-title":"Time-lapse live-cell imaging of pyroptosis by confocal microscopy","volume":"4","author":"Jiang","year":"2023","journal-title":"STAR Protoc"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0835","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/bjd\/ljae179","article-title":"Gasdermin E-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation","volume":"191","author":"Li","year":"2024","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103815_bb0840","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.autrev.2025.103815_bb0845","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fimmu.2017.00164","article-title":"Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model","volume":"8","author":"Carlos","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103815_bb0850","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/bpa.12477","article-title":"Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"27","author":"Barclay","year":"2017","journal-title":"Brain Pathol"},{"issue":"14","key":"10.1016\/j.autrev.2025.103815_bb0855","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1177\/0961203316644336","article-title":"Association between functional NLRP3 polymorphisms and susceptibility to autoimmune and inflammatory diseases: a meta-analysis","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0860","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mus.27193","article-title":"Investigating the possible association between NLRP3 gene polymorphisms and myasthenia gravis","volume":"63","author":"Agah","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2025.103815_bb0865","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fped.2019.00063","article-title":"Dual role of PTPN22 but not NLRP3 inflammasome polymorphisms in type 1 diabetes and celiac disease in children","volume":"7","author":"Smigoc Schweiger","year":"2019","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0870","first-page":"249","article-title":"Association of three functional polymorphisms in the NLRP3 gene with susceptibility to rheumatoid arthritis in the Iranian population","volume":"18","author":"Nasrollahzadeh Sabet","year":"2021","journal-title":"Iran J Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103815_bb0875","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3390\/ijms25115793","article-title":"The association between genetics and response to treatment with biologics in patients with psoriasis, psoriatic arthritis, rheumatoid arthritis, and inflammatory bowel diseases: a systematic review and meta-analysis","volume":"25","author":"Al-Sofi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0880","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/03009740310003974","article-title":"Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome","volume":"32","author":"Federico","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103815_bb0885","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00381-006-1280-3","article-title":"Hydrocephalus in CINCA syndrome treated with anakinra","volume":"22","author":"Rigante","year":"2006","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"10.1016\/j.autrev.2025.103815_bb0890","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/039463201002300303","article-title":"Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature","volume":"23","author":"Cantarini","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103815_bb0895","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67380-4","article-title":"Long-term renal outcome of cryopyrin-associated periodic syndrome (CAPS) under anti-interleukin-1 therapy","volume":"14","author":"Russwurm","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.autrev.2025.103815_bb0900","first-page":"301","article-title":"Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications","volume":"11","author":"De Rosa","year":"2007","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.autrev.2025.103815_bb0905","article-title":"Kawasaki disease and coronary artery involvement: a narrative review","volume":"14","author":"Rajasekaran","year":"2022","journal-title":"Cureus"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T15:06:49Z","timestamp":1749308809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":181,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1568997225000758"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103815","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103815"}}